转化生长因子-β在异常瘢痕形成中的作用证据。
The evidence for the role of transforming growth factor-beta in the formation of abnormal scarring.
机构信息
Department of Plastic and Reconstructive Surgery, University Hospital of North Durham, Durham, UK.
出版信息
Int Wound J. 2011 Jun;8(3):218-23. doi: 10.1111/j.1742-481X.2011.00771.x. Epub 2011 Mar 30.
Abstract
The complex biological and physiological mechanisms that result in poor quality scarring are still not fully understood. This review looks at current evidence of the role of transforming growth factor-beta (TGFβ) in this pathological process.
摘要
导致瘢痕质量差的复杂生物学和生理学机制仍未被完全理解。本综述着眼于目前转化生长因子-β（TGFβ）在这一病理过程中的作用证据。
相似文献
1
The evidence for the role of transforming growth factor-beta in the formation of abnormal scarring.转化生长因子-β在异常瘢痕形成中的作用证据。
Int Wound J. 2011 Jun;8(3):218-23. doi: 10.1111/j.1742-481X.2011.00771.x. Epub 2011 Mar 30.
2
The pathogenesis of hypertrophic/keloid scarring.肥厚性/瘢痕疙瘩性瘢痕形成的发病机制。
Int J Oral Maxillofac Surg. 1994 Aug;23(4):232-6. doi: 10.1016/s0901-5027(05)80377-7.
3
The molecular biology of fibroproliferative disorders of the skin: potential cytokine therapeutics.皮肤纤维增生性疾病的分子生物学：潜在的细胞因子疗法。
Ann Plast Surg. 1994 Aug;33(2):152-4.
4
Mathematical modelling of nitric oxide activity in wound healing can explain keloid and hypertrophic scarring.伤口愈合中一氧化氮活性的数学模型可以解释瘢痕疙瘩和增生性瘢痕的形成。
J Theor Biol. 2000 May 21;204(2):257-88. doi: 10.1006/jtbi.2000.2012.
5
Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management.瘢痕疙瘩与瘢痕：瘢痕疙瘩和瘢痕的综述，包括其发病机制、危险因素及治疗。
Curr Opin Pediatr. 2006 Aug;18(4):396-402. doi: 10.1097/01.mop.0000236389.41462.ef.
6
Oncostatin M exerts a protective effect against excessive scarring by counteracting the inductive effect of TGFβ1 on fibrosis markers.抑瘤素 M 通过拮抗 TGFβ1 对纤维化标志物的诱导作用，发挥抗过度瘢痕形成的保护作用。
Sci Rep. 2019 Feb 14;9(1):2113. doi: 10.1038/s41598-019-38572-0.
7
Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation.针对 TGF-β/Smad 信号通路的当前潜在治疗策略，以减轻瘢痕疙瘩和增生性瘢痕的形成。
Biomed Pharmacother. 2020 Sep;129:110287. doi: 10.1016/j.biopha.2020.110287. Epub 2020 Jun 12.
8
Modulation of collagen synthesis by transforming growth factor-beta in keloid and hypertrophic scar fibroblasts.转化生长因子-β对瘢痕疙瘩和增生性瘢痕成纤维细胞胶原合成的调节作用
Ann Plast Surg. 1994 Aug;33(2):148-51. doi: 10.1097/00000637-199408000-00005.
9
[Changes in TGF-beta 1 and type I, III procollagen gene expression in keloid and hypertrophic scar].[瘢痕疙瘩和增生性瘢痕中转化生长因子-β1及Ⅰ型、Ⅲ型前胶原基因表达的变化]
Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi. 1999 Jul;15(4):283-5.
10
Wnt Signaling Pathway Proteins in Scar, Hypertrophic Scar, and Keloid: Evidence for a Continuum?瘢痕、增生性瘢痕和瘢痕疙瘩中的 Wnt 信号通路蛋白：连续体的证据？
Am J Dermatopathol. 2020 Nov;42(11):842-847. doi: 10.1097/DAD.0000000000001661.
引用本文的文献
1
Remdesivir alleviates skin fibrosis by suppressing TGF-β1 signaling pathway.瑞德西韦通过抑制 TGF-β1 信号通路缓解皮肤纤维化。
PLoS One. 2024 Jul 18;19(7):e0305927. doi: 10.1371/journal.pone.0305927. eCollection 2024.
2
Stem cell-based therapy for fibrotic diseases: mechanisms and pathways.基于干细胞的纤维化疾病治疗：机制与途径。
Stem Cell Res Ther. 2024 Jun 18;15(1):170. doi: 10.1186/s13287-024-03782-5.
3
Platycodin D inhibits the proliferation and migration of hypertrophic scar-derived fibroblasts and promotes apoptosis through a caspase-dependent pathway.桔梗皂苷 D 通过 caspase 依赖性途径抑制增生性瘢痕成纤维细胞的增殖和迁移，并促进细胞凋亡。
Arch Dermatol Res. 2023 Jul;315(5):1257-1267. doi: 10.1007/s00403-022-02513-1. Epub 2022 Dec 16.
4
Alpinetin Suppresses Effects of TGF-β1 on Stimulating the Production and Organization of Fibrotic Markers in Human Primary Dermal Fibroblasts.白杨素抑制 TGF-β1 刺激人原代真皮成纤维细胞产生和组织纤维化标志物的作用。
Cells. 2022 Sep 1;11(17):2731. doi: 10.3390/cells11172731.
5
Macrophage Phenotypes in Normal and Diabetic Wound Healing and Therapeutic Interventions.巨噬细胞表型在正常和糖尿病伤口愈合及治疗干预中的作用。
Cells. 2022 Aug 5;11(15):2430. doi: 10.3390/cells11152430.
6
Adipose-Derived Stromal/Stem Cell Response to Tumors and Wounds: Evaluation of Patient Age.脂肪组织来源的基质/干细胞对肿瘤和创伤的反应：患者年龄的评估。
Stem Cells Dev. 2022 Oct;31(19-20):579-592. doi: 10.1089/scd.2021.0280. Epub 2022 May 16.
7
Pinocembrin Ameliorates Skin Fibrosis via Inhibiting TGF-β1 Signaling Pathway.白杨素通过抑制转化生长因子-β1信号通路改善皮肤纤维化。
Biomolecules. 2021 Aug 19;11(8):1240. doi: 10.3390/biom11081240.
8
Prevention of excessive scar formation using nanofibrous meshes made of biodegradable elastomer poly(3-hydroxybutyrate--3-hydroxyvalerate).使用由可生物降解弹性体聚（3-羟基丁酸酯-3-羟基戊酸酯）制成的纳米纤维网预防过度瘢痕形成。
J Tissue Eng. 2020 Aug 23;11:2041731420949332. doi: 10.1177/2041731420949332. eCollection 2020 Jan-Dec.
9
Mesenchymal Stem Cells Adaptively Respond to Environmental Cues Thereby Improving Granulation Tissue Formation and Wound Healing.间充质干细胞可适应性地响应环境信号，从而促进肉芽组织形成和伤口愈合。
Front Cell Dev Biol. 2020 Jul 29;8:697. doi: 10.3389/fcell.2020.00697. eCollection 2020.
10
Role of TGF-β in Skin Chronic Wounds: A Keratinocyte Perspective.TGF-β 在皮肤慢性伤口中的作用：角化细胞的观点。
Cells. 2020 Jan 28;9(2):306. doi: 10.3390/cells9020306.
本文引用的文献
1
Recombinant human decorin inhibits TGF-beta1-induced contraction of collagen lattice by hypertrophic scar fibroblasts.重组人 decorin 通过抑制 TGF-β1 诱导的增生性瘢痕成纤维细胞收缩胶原格子。
Burns. 2009 Jun;35(4):527-37. doi: 10.1016/j.burns.2008.08.021. Epub 2009 Jan 23.
2
Wound healing: an overview.伤口愈合：概述
Plast Reconstr Surg. 2006 Jun;117(7 Suppl):1e-S-32e-S. doi: 10.1097/01.prs.0000222562.60260.f9.
3
Upregulation of TGF-beta1 expression may be necessary but is not sufficient for excessive scarring.转化生长因子-β1（TGF-β1）表达上调可能是瘢痕过度增生所必需的，但并不充分。
J Invest Dermatol. 2006 May;126(5):1168-76. doi: 10.1038/sj.jid.5700200.
4
Keloid pathogenesis and treatment.瘢痕疙瘩的发病机制与治疗
Plast Reconstr Surg. 2006 Jan;117(1):286-300. doi: 10.1097/01.prs.0000195073.73580.46.
5
Hypertrophic response and keloid diathesis: two very different forms of scar.肥厚性反应和瘢痕疙瘩素质：两种截然不同的瘢痕形式。
Plast Reconstr Surg. 2005 Dec;116(7):150e-157e. doi: 10.1097/01.prs.0000191977.51206.43.
6
Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration.瘢痕疙瘩来源的成纤维细胞显示出参与胶原蛋白周转的因子分泌增加，并且迁移依赖基质金属蛋白酶。
Br J Dermatol. 2005 Aug;153(2):295-300. doi: 10.1111/j.1365-2133.2005.06698.x.
7
Genetic susceptibility to keloid disease: transforming growth factor beta receptor gene polymorphisms are not associated with keloid disease.瘢痕疙瘩病的遗传易感性：转化生长因子β受体基因多态性与瘢痕疙瘩病无关。
Exp Dermatol. 2004 Feb;13(2):120-4. doi: 10.1111/j.0906-6705.2004.00165.x.
8
Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels.瘢痕疙瘩病和增生性瘢痕形成的遗传易感性：转化生长因子β1常见多态性与血浆水平
Plast Reconstr Surg. 2003 Feb;111(2):535-43; discussion 544-6. doi: 10.1097/01.PRS.0000041536.02524.A3.
9
Triamcinolone stimulates bFGF production and inhibits TGF-beta1 production by human dermal fibroblasts.曲安奈德刺激人皮肤成纤维细胞产生碱性成纤维细胞生长因子并抑制转化生长因子-β1的产生。
Dermatol Surg. 2002 Aug;28(8):704-9. doi: 10.1046/j.1524-4725.2002.02012.x.
10
Brief exposure to high-dose transforming growth factor-beta1 enhances periosteal chondrogenesis in vitro: a preliminary report.短期暴露于高剂量转化生长因子-β1可增强体外骨膜软骨形成：初步报告。
J Bone Joint Surg Am. 2002 May;84(5):793-9. doi: 10.2106/00004623-200205000-00015.
Zotero 插件